← All organizations
Highest phase reached
Phase 4
First clinical trial
Jun 1, 2014Last known activity
Apr 30, 2020
Timeline
2010s
- Jun 1, 2014
CJ HealthCare Corp.— Founded
Drugs by trial phase (59 distinct, 76 trials)
Phase 4 (20 own, 0 via acquisition)
Phase 3 (9 own, 0 via acquisition)
Phase 2 (4 own, 0 via acquisition)
Phase 1 (24 own, 0 via acquisition)
Other trials (2 own, 0 via acquisition)
Indications
Studied for
- Altitude Sickness
- Breast Neoplasms
- Coronary Artery Disease
- Diabetes Mellitus
- Digestive System Diseases
- Digestive System Neoplasms
- Disease
- Disease Progression
- Dyssomnias
- Esophagitis
- Essential Hypertension
- Fibrosis
- Foot-and-Mouth Disease
- Gastroesophageal Reflux
- Gastrointestinal Diseases
- Gastrointestinal Neoplasms
- Hand, Foot and Mouth Disease
- Heartburn
- Hyperlipidemias
- Hyperlipoproteinemias
- Hypertension
- Kidney Diseases
- Liver Cirrhosis
- Mouth Diseases
- Nausea
- Parasomnias
- Postoperative Nausea and Vomiting
- Psychotic Disorders
- Renal Insufficiency, Chronic
- Rhinitis
- Rhinitis, Allergic
- Rhinitis, Allergic, Perennial
- Schizophrenia
- Sleep Wake Disorders
- Smallpox
- Stomach Ulcer
- Ulcer
- Vomiting
Recent trials (50)
- NCT04309916Lead sponsorPhase 4Apr 30, 2020
- NCT04231136Lead sponsorPhase 1Jan 14, 2020
- NCT04221321Lead sponsorPhase 1Jan 7, 2020
- NCT04182932Lead sponsorPhase 1Dec 2, 2019
- NCT04128917Lead sponsorPhase 3Oct 31, 2019
- NCT04171687Lead sponsorPhase 1Oct 21, 2019
- NCT04022096Lead sponsorPhase 3Jun 18, 2019
- NCT03863938Lead sponsorPhase 1Mar 27, 2019
- NCT03814642Lead sponsorPhase 1Jan 21, 2019
- NCT04066257Lead sponsorPhase 1Jan 17, 2019
- NCT03757390Lead sponsorPhase 1Nov 9, 2018
- NCT03847506Lead sponsorPhase 4Jul 5, 2018
- NCT03498456Lead sponsorPhase 3Jun 28, 2018
- NCT03530228Lead sponsorPhase 1May 31, 2018
- NCT03639493Lead sponsorPhase 1Apr 6, 2018
Details
- Founded
- Seoul, KR Jun 1, 2014
- Last known activity
- Apr 30, 2020